BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16650963)

  • 1. Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer.
    McCarthy K; Bustin SA; Ogunkolade B; Khalaf S; Laban CA; McVittie CJ; Carpenter R; Jenkins PJ
    Eur J Surg Oncol; 2006 Sep; 32(7):707-9. PubMed ID: 16650963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer.
    Singh-Ranger G; Kirkpatrick KL; Clark GM; Mokbel K
    Curr Med Res Opin; 2003; 19(2):131-4. PubMed ID: 12740157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.
    Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.
    Salhab M; Singh-Ranger G; Mokbel R; Jouhra F; Jiang WG; Mokbel K
    J Surg Oncol; 2007 Oct; 96(5):424-8. PubMed ID: 17657731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 expression does not correlate with microvessel density in breast cancer.
    Thorat MA; Mehrotra S; Morimiya A; Badve S
    Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
    J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
    Smith RA; Lea RA; Weinstein SR; Griffiths LR
    Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
    Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
    Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
    Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prolactin receptor mRNA in oestrogen receptor positive breast cancers pre- and post-tamoxifen therapy.
    de Castillo B; Cawthorn S; Moppett J; Shere M; Norman M
    Eur J Surg Oncol; 2004 Jun; 30(5):515-9. PubMed ID: 15135479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can cyclo-oxygenase-2 be a useful prognostic and risk stratification marker in breast cancer?
    Jana D; Sarkar DK; Maji A; Chikkala BR; Hassanujjaman S; Mukhopadhyay M; Ganguly S
    J Indian Med Assoc; 2012 Jul; 110(7):429-33. PubMed ID: 23520664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of the cyclooxygenase-2 gene in human breast carcinoma].
    Zhao XQ; Pang D; Xue YW
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):427-9. PubMed ID: 12895350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.